Comparison of retinal vascular geometry in obese and non-obese children

Evelyn Li Min Tai1,2, Yee Cheng Kueh3, Wan-Hazabbah Wan Hitam1,2

  • 1Department of Ophthalmology, School of Medical Sciences, Health Campus, Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia.

Plos One
|February 2, 2018
PubMed

Insights

Childhood obesity is linked to early microvascular changes, as obese children show abnormal retinal vascular geometry compared to non-obese peers. These findings suggest potential biomarkers for obesity risk stratification.

Area of Science:

  • Ophthalmology
  • Pediatrics
  • Cardiology

Background:

  • Childhood obesity is a growing concern, associated with adult cardiometabolic diseases.
  • Microvascular dysfunction may originate in childhood, preceding overt disease development.

Purpose of the Study:

  • To investigate and compare retinal vascular parameters between obese and non-obese children.
  • To explore early indicators of microvascular changes in pediatric obesity.

Main Methods:

  • Cross-sectional study of 166 Malaysian children (6-12 years old).
  • Measurements included ocular examination, biometry, retinal photography, blood pressure, and body mass index.
  • Retinal vascular parameters were analyzed using validated software and compared between obese and non-obese groups.

Main Results:

  • Obese children exhibited significantly narrower retinal arteriolar caliber.
  • Lower arteriovenous ratio was observed in obese children.
  • Obese children showed higher venular fractal dimension and venular curvature tortuosity compared to non-obese children, after adjustments.

Conclusions:

  • Obese children present with abnormal retinal vascular geometry, indicating early microvascular abnormalities.
  • These retinal changes suggest that microvascular dysfunction associated with obesity begins in childhood.
  • Retinal vascular parameters may serve as potential biomarkers for risk stratification in pediatric obesity.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.4K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
269
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
300
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
197
Coordination Number and Geometry02:57

Coordination Number and Geometry

For transition metal complexes, the coordination number determines the geometry around the central metal ion. Table 1 compares coordination numbers to molecular geometry. The most common structures of the complexes in coordination compounds are octahedral, tetrahedral, and square planar.
19.1K
Predicting Molecular Geometry02:27

Predicting Molecular Geometry

VSEPR Theory for Determination of Electron Pair Geometries
46.2K